Evidence map›Paper›PMID 17460126›Full record

Trial reportJournal of the American Medical Informatics Association : JAMIA

Randomized trial to improve prescribing safety during pregnancy.

Marsha A Raebel, Nikki M Carroll, Julia A Kelleher, Elizabeth A Chester, Sally Berga, David J Magid

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Medical Informatics Association : JAMIA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 6 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 6 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Detecting pregnancy use of non-hormonal category X medications in electronic medical records.Journal of the American Medical Informatics Association : JAMIA · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marsha A RaebelKaiser Permanente Colorado Clinical Research Unit, PO Box 378066, Denver, CO 80237-8066, USA. marsha.a.raebel@kp.org
Nikki M Carroll
Julia A Kelleher
Elizabeth A Chester
Sally Berga
David J Magid
University of Colorado Health · USColorado Permanente Medical Group · USUniversity of Colorado Denver · US

Funding

Improving Drug Safety: Linking Lab and Pharmacy DataUC1HS014249 · AHRQ · KAISER FOUNDATION RESEARCH INSTITUTE · PI MAGID, DAVID J · 2003 to 2004
–
AHRQ HHS 1UC1HS014249AHRQ HHS UC1 HS014249
6 · The paper itself

Abstract

objectiveThis study sought to determine whether a computerized tool that alerted pharmacists when pregnant patients were prescribed U.S. Food and Drug Administration pregnancy risk category D or X medications was effective in decreasing dispensings of these medications.

designRandomized trial. Pharmacy, diagnostic, and laboratory data were linked to identify pregnant patients prescribed targeted medications. Women (n = 11,100) were randomized to intervention or usual care. Physicians and pharmacists collaborated on the intervention. MEASUREMENTS: The primary outcome was the proportion of pregnant women dispensed a category D or X medication. The secondary outcome was the total number of first dispensings of targeted medications.

resultsA total of 2.9% of intervention (n = 177) and 5.5% of usual care (n = 276) patients were dispensed targeted medications (p < 0.001): 1.8% of intervention (n = 108) and 3.9% of usual care (n = 198) patients were dispensed only category D medication(s); 0.9% of intervention (n = 54) and 1.2% of usual care (n = 58) patients were dispensed only category X medication(s); 0.2% of intervention (n = 15) and 0.4% of usual care (n = 20) patients were dispensed both category D and X medications (p = 0.05). This resulted in intervention patients receiving 238 dispensings of unique targeted medications and usual care patients receiving 361 dispensings of unique targeted medications (p = 0.03). The study was stopped primarily due to 2 false-positive alert types: Misidentification of medications as contraindicated in pregnancy by the pharmacy information system and misidentification of pregnancy related to delayed transfer of diagnosis information.

conclusionCoupling data from information systems with knowledge and skills of physicians and pharmacists resulted in improved prescribing safety. Systems limitations contributed to project discontinuation. Linking ambulatory clinical, laboratory, and pharmacy information to provide safety alerts is not sufficient to ensure project success and sustainability.

Indexed as

Clinical Pharmacy Information SystemsDrug Therapy, Computer-AssistedMedical Order Entry SystemsAdolescentAdultAge DistributionChi-Square DistributionDrug PrescriptionsDrug-Related Side Effects and Adverse ReactionsFemaleHumansMedication ErrorsMiddle AgedPregnancyReminder Systems

Identifiers

PMID17460126
PMCPMC2244894
OpenAlexW2123174571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.